References
- Arikan SK, Kasap B, Yetimalar H, et al (2014). Impact of prognostic factors on survival rates in patients with ovarian carcinoma. Asian Pac J Cancer Prev, 15, 6087-94. https://doi.org/10.7314/APJCP.2014.15.15.6087
- Arun-Muthuvel V, Jaya V (2014). Pre-operative evaluation of ovarian tumors by risk of malignancy index, CA125 and ultrasound. Asian Pac J Cancer Prev, 15, 2929-32. https://doi.org/10.7314/APJCP.2014.15.6.2929
- Bartella L, Morris EA, Dershaw DD, et al (2006). Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiol, 239, 686-92. https://doi.org/10.1148/radiol.2393051046
- Booth SJ, Pickles MD, Turnbull LW (2009). In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla. BJOG, 116, 300-3. https://doi.org/10.1111/j.1471-0528.2008.02007.x
- Boyle P, Maisonneuve P, Autier P (2000). Update on cancer control in women. Int J Gynaecol Obstet, 70, 263-303. https://doi.org/10.1016/S0020-7292(00)00298-8
- Esseridou A, Di Leo G, Sconfienza LM, et al (2011). In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy. Invest Radiol, 46, 377-82. https://doi.org/10.1097/RLI.0b013e31821690ef
- Karadag B, Kocak M, Kayikcioglu F, et al (2014). Risk for malignant and borderline ovarian neoplasms following basic preoperative evaluation by ultrasonography, ca125 level and age. Asian Pac J Cancer Prev, 15, 8489-93. https://doi.org/10.7314/APJCP.2014.15.19.8489
- Kunpalin Y, Triratanachat S, Tantbirojn P (2014). Proportion of ovarian cancers in overall ovarian masses in Thailand. Asian Pac J Cancer Prev, 15, 7929-34. https://doi.org/10.7314/APJCP.2014.15.18.7929
- Mohaghegh P, Rockall AG (2012). Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques. Radiographics, 32, 1751-73. https://doi.org/10.1148/rg.326125520
- Negendank W (1992). Studies of human tumors by MRS: a review. NMR Biomed, 5, 303-24. https://doi.org/10.1002/nbm.1940050518
- Oz G, Alger JR, Barker PB, et al (2014). Clinical proton MR spectroscopy in central nervous system disorders. Radiol, 270, 658-79. https://doi.org/10.1148/radiol.13130531
- Ozbay PO, Ekinci T, Caltekin MD, et al (2015). Comparative evaluation of the risk of malignancy index scoring systems (1-4) used in differential diagnosis of adnexal masses. Asian Pac J Cancer Prev, 16, 345-9. https://doi.org/10.7314/APJCP.2015.16.1.345
- Simsek HS, Tokmak A, Ozgu E, et al (2014). Role of a risk of malignancy index in clinical approaches to adnexal masses. Asian Pac J Cancer Prev, 15, 7793-7. https://doi.org/10.7314/APJCP.2014.15.18.7793
- Stanwell P, Russell P, Carter J, et al (2008). Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla. Invest Radiol, 43, 745-51. https://doi.org/10.1097/RLI.0b013e31817e9104
- Swindle P, McCredie S, Russell P, et al (2003). Pathologic characterization of human prostate tissue with proton MR spectroscopy. Radiol, 228, 144-51. https://doi.org/10.1148/radiol.2281011808
- Takeuchi M, Matsuzaki K, Nishitani H (2010). Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr, 34, 173-6. https://doi.org/10.1097/RCT.0b013e3181c2f0a2
- Tantipalakorn C, Wanapirak C, Khunamornpong S, et al (2014). IOTA simple rules in differentiating between benign and malignant ovarian tumors. Asian Pac J Cancer Prev, 15, 5123-6. https://doi.org/10.7314/APJCP.2014.15.13.5123
- Thomassin-Naggara I, Bazot M, Darai E, et al (2008). Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiol, 248, 148-59. https://doi.org/10.1148/radiol.2481071120
- Thomassin-Naggara I, Toussaint I, Perrot N, et al (2011). Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiol, 258, 793-803. https://doi.org/10.1148/radiol.10100751